Advertisement

Topics

STAT Plus: A biotech goes quiet on pivotal trial of a cancer vaccine, as doctors, investors, patients are left to wonder

04:30 EST 15 Feb 2018 | STAT

Northwest Biotherapeutics said its trial of an experimental brain cancer treatment was ready to be analyzed a year ago. What happened to it?

Original Article: STAT Plus: A biotech goes quiet on pivotal trial of a cancer vaccine, as doctors, investors, patients are left to wonder

NEXT ARTICLE

More From BioPortfolio on "STAT Plus: A biotech goes quiet on pivotal trial of a cancer vaccine, as doctors, investors, patients are left to wonder"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology Products
BioPortfolio lists over 550 biotechnology products - please open http://www.bioportfolio.com/channels?category_id=5 Direct topic pages: Actos Advair Biopharmaceuticals Biosimilars Biotherapeutics GMO Crops Lipitor ...

Brain Cancer
According to the American Brain Tumor Association, just over 24,000 patients will be diagnosed with a primary malignant brain tumour during 2012 in the US alone. Some 80% of primary malignant brain tumours are gliomas, a broad term which includes all tum...